• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Friday, October 10
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Biotech News»IISER Bhopal Scientists Invent Technology For Precise Engineering Of Proteins

IISER Bhopal Scientists Invent Technology For Precise Engineering Of Proteins

0
By Biotech Express on 07/06/2021 Biotech News, News-Research

The research team from the Departments of Chemistry and Biological Sciences at IISER Bhopal includes Dr Vishal Rai, Dr Ram Kumar Mishra, Dr Sanjeev Shukla, Dr Srinivasa Rao Adusumalli, Dr Dattatraya Gautam Rawale, and Dr Neetu Kalra, among others who have worked on this novel research.

The development of their Linchpin Directed Modification (LDM) platform has been described in three papers published in the Journal of the American Chemical Society (2018), Angewandte Chemie (International Edition – 2020), and Chemical Science (2021).

Explaining the significance of this research, Dr Vishal Rai, Associate Professor and Swarnajayanti Fellow, Department of Chemistry, IISER Bhopal, said, “Our team believes that successful platforms for precision engineering of proteins depend on the core understanding of molecular and social behaviour of proteins in the chemical reactions.” “A key advantage of our LDM platform is that it does not modify the structure or functions of the native protein,” explained Dr Rai.

“The LDM platform provides unprecedented control over precision in protein engineering and a very powerful chemical toolbox for biology and medicine,” said the lead researcher.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”

KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam

Zydus to launch market-specific dosage variants of Semaglutide, MD says

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.